DONOR CHARACTERISTICS AS RISK FACTORS IN RECIPIENTS AFTER TRANSPLANTATION OF BONE MARROW FROM UNRELATED DONORS: THE EFFECT OF DONOR AGE
Main Article Content
Keywords
Age, Bone Marrow, Donor, Recipient, Transplantation
Abstract
INTRODUCTION
Utilizing marrow from unrelated volunteer donors is an established method of treatment for individuals requiring an allogeneic stem cell transplant but lacking a sibling donor with matching HLA. The aim of present study is to “assess the donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors & to report associations between outcome & donor age”.
MATERIAL & METHODS
The present retrospective study was conducted at a tertiary care centre among patients who required bone marrow transplantation during the duration of study (2 years). Through convenient sampling a total 100 patients who underwent bone marrow transplantation from an unrelated donor were selected on the basis of inclusion & exclusion criteria. The evaluation addressed possible effects of cytomegalovirus serologic status, donor age, sex & ABO compatibility on overall & disease free survival.
RESULTS
The recipient characteristics according to age with respect to gender, mean age, mean time, diseases, CMMV status, match status & GVHD prophylaxis was tabulated. Age was the only donor trait significantly associated with overall & disease-free survival. All the patient of transplantation survived (100) whereas those who survived disease free were 90. Only the age & HLA matching of the donors were shown to be substantially linked with overall or disease-free survival (P < .0001).
CONCLUSION
Utilizing younger donors has the potential to decrease the occurrence of illness & enhance the likelihood of survival following bone marrow transplantation. Age should be taken into account when choosing from a pool of volunteer donors that have similar HLA compatibility.
References
2. Thomas ED, Lochte HL, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation & chemotherapy. N Engl J Med 1957;257(11):491-6.
3. Hansen JA, Clift RA, Thomas ED, Buckner CD, Storb R, Giblett ER. Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 1980;303:1311-8.
4. Beatty PG, Hansen JA, Longton GM, Thomas ED, Sanders JE, Martin PJ, et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991;51(2):443-7.
5. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, et al. Analysis of 462 transplants from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328(9):593-602.
6. McGlave P, Bartsch G, Anasetti C, Ash R, Beatty P, Gajewski J, et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood 1993;8:543-50.
7. Armitage JO. Bone marrow transplantation. N Engl J Med 1994;330:827-33.
8. Szydlo R, Goldman J, Klein JP, Gale RP, Ash RC, Bach FH, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J ClinOncol 1997;15(5):1767-77.
9. Weisdorf DJ, Billett AL, Hannan P, Ritz J, Sallan SE, Steinbuch M, et al. Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood 1997;90(8):2962-8.
10. Zumwalt ER, Howe CWS. The origins & development of the National Marrow Donor Program. Leukemia 1993;7:1122.
11. National Marrow Donor Program Standards Committee. Standards of the National Marrow Donor Program. Transfus Med Rev 1993;33(7):172-80.
12. Perkins HA, Hansen JA. The U.S. National Marrow Donor Program. Am J PediatrHematolOncol1994;16(1):30-4.
13. PetersdorfEW, Smith AG, Mickelson EM, Longton GM, Anasetti C, ChooSY, et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 1993;82(7):1923-32.
14. PetersdorfEW, Longton GM, Anasetti C, Mickelson EM, Smith AG, Hansen JA. Definition of HLA-DQ as a transplantation antigen. ProcNatlAcadSci U S A 1996;93(26):15358-63.
15. PetersdorfEW, Longton GM, Anasetti C, Mickelson EM, McKinney SK, Smith AG, et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997;89(5):1818-23.
16. BroersAEC, van der Hold R, van EsserJWJ, GratamaJW, Henzen-Logmans S, Kuenen-Boumeester V, et al. Increased transplant-related morbidity & mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell–depleted stem cell transplantation. Blood 2000;95(7):2240-5.
17. Miller W, Flynn P, McCullough J, Balfour HJ, Goldman A, Haake R, et al. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood 1986;67(4):1162-7.
18. Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA,et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998;338(14):962-8.
19. Benjamin RJ, McGurk S, Ralston MS, Churchill WH, AntinJH. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 1999;39(2):179-87.
20. Bensinger WI, Buckner CD, Thomas ED, Clift RA. ABO-incompatible marrow transplants. Transplantation 1982;33:427-9.
21. Mehta J, Powles R, Horton C, Milan S, Singhal S, Treleaven J. Relationship between donor-recipient blood group incompatibility & serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings. Bone Marrow Transplant 1995;15(6):853-8.
22. Beatty P, Mori M, Milford E. Impact of racial genetic polymorphism upon the probability of finding an HLA-matched donor. Transplantation 1995;60(8):778-83.
23. JonssonJI, Phillips RA. Interleukin-7 responsiveness of B2201 B cell precursors from bone marrow decreases in aging mice. CellImmunol 1993;147(2):267-78.
24. Merchant MS, Garvy BA, Riley RL. B2202 bone marrow progenitor cells from New Zealand black autoimmune mice exhibit an age-associated decline in Pre-B & B-cell generation. Blood 1995;85(7):1850-7.
25. Stephan RP, Reilly CR, Witte PL. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 1998;91(1):75-88.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Pawan Kumar
Assistant Professor, Department of Pathology and Blood Bank, Autonomous State Medical College, Hardoi, Uttar Pradesh, India.
Dr. Swaraj Kumar Sharma
Associate Professor, Department of Pathology and Blood Bank, Maharshi Vashishtha Autonomous State Medical College, Basti, Uttar Pradesh, India
Dr. Garima Singh
Associate Professor, Department of Pathology and Blood Bank, Autonomous State Medical College, Firozabad, Uttar Pradesh, India.
Dr. Manoj Kumar Gupta
Professor, Department of Pathology and Blood Bank, MRA Medical College, Ambedkar Nagar, Uttar Pradesh, India.